Emily C. Williams

Education
PhD University of Washington, 2009 (Health Services)MPH Boston University, 2003 (Health Policy, Health Law)
BA Lewis And Clark College, 1998 (Political Science)
Contact Info
email: emwilli@uw.eduoffice: HRC 443
address:
3980 15th Ave NE
Seattle, WA 98195-1621
campus box: 351621
voice: 206-685-5048
About
Emily Williams is an addictions health services and disparities researcher and an implementation scientist. She serves as Professor of Health Systems and Population Health and Director of the Doctoral Program in Health Services at the University of Washington. She also has affiliate appointments at the Denver-Seattle Center of Innovation for Veteran-Centered Value-Driven Care at VA Puget Sound Health Services Research & Development (HSR&D) and Kaiser Permanente Washington Health Research Institute. She is interested in the influence of contextual mechanisms on health behavior, health care, health outcomes, and health disparities, particularly with regard to vulnerable populations with stigmatized conditions. Her research focuses on increasing access to needed prevention and treatment for stigmatized conditions, including unhealthy alcohol, opioid, and other substance use, hepatitis C, HIV, as well as understanding and promoting equity in this care for vulnerable patient subpopulations (e.g., those with HIV and HCV, racial/ethnic minorities, persons living in rural areas, transgender patients, and women). She currently leads research on tailoring and testing practice facilitation to implement evidence-based alcohol-related care in liver clinics and increasing access to evidence-based treatment for opioid use disorders in primary care.
Williams EC, Chen JA, Frost MC, Rubinsky AD, Edmonds AT, Glass JE, Lehavot K, Matson TE, Wheat CL, Coggeshall S, Blosnich JR. Receipt of evidence-based alcohol-related care in a national sample of transgender patients with unhealthy alcohol use: Overall and relative to non-transgender patients. J Subst Abuse Treat. 2021 Jul 8:108565. doi: 10.1016/j.jsat.2021.108565. [Epub ahead of print] PMID: 34274175
Chen J, Cabudol M, Williams EC, Merrill JO, Tsui JI, Klein JW. Perspectives on electronic portal use among patients treated with medications for opioid use disorder in primary care. J Subst Abuse Treat. 2021 Jul;126:108463. doi: 10.1016/j.jsat.2021.108463. Epub 2021 May 7. PMID: 34116814
Frost MC, Sweek EW, Austin EJ, Corcorran MA, Juarez AM, Frank ND, Prohaska SM, LaKosky PA, Asher AK, Broz D, Jarlais DCD, Williams EC, Glick SN. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S. AIDS Behav. 2021 Jun 10. doi: 10.1007/s10461-021-03332-7. [Epub ahead of print] PMID: 34110506 PMCID: PMC8190167
Kennedy AJ, McGinnis KA, Merlin JS, Edelman EJ, Gordon AJ, Korthuis PT, Skanderson M, Williams EC, Wyse J, Oldfield B, Bryant K, Justice A, Fiellin DA, Kraemer KL. Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV. J Subst Abuse Treat. 2021 May 29;132:108509. doi: 10.1016/j.jsat.2021.108509. [Epub ahead of print] PMID: 34130128
PI: Williams Dates: 4/1/2022 - 3/31/2027
PI: Williams Dates: 7/1/2021 - 2/28/2022
PI: Williams Dates: 7/1/2021 - 2/28/2022
PI: Williams Dates: 7/1/2021 - 6/30/2026
PI: Fortney Dates: 10/1/2019 - 9/30/2024
PI: Tsui Dates: 9/1/2019 - 8/31/2020
PI: Tsui Dates: 7/1/2019 - 6/30/2022
PI: Williams Dates: 4/1/2018 - 3/31/2020